As noted in the Results, we detected in cancer tissue an alteration parallel to that of hnRNP A1 in both the protein and mRNA levels of ASF/SF2, a factor with a known antagonistic role to A1 in alternative splicing [12]. The gene discussed is SRSF1; the disease is cancer.